Chuan‐Chou Tu

756 total citations
17 papers, 631 citations indexed

About

Chuan‐Chou Tu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chuan‐Chou Tu has authored 17 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Chuan‐Chou Tu's work include Nigella sativa pharmacological applications (3 papers), NF-κB Signaling Pathways (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Chuan‐Chou Tu is often cited by papers focused on Nigella sativa pharmacological applications (3 papers), NF-κB Signaling Pathways (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Chuan‐Chou Tu collaborates with scholars based in Taiwan, India and Vietnam. Chuan‐Chou Tu's co-authors include Chih‐Yang Huang, Wei‐Wen Kuo, Ming‐Cheng Chen, Hsi‐Hsien Hsu, Yueh‐Min Lin, Hsi-Hsien Hsu, Tsung‐Jung Ho, Ming-Cheng Chen, Cecilia Hsuan Day and Vijaya Padma Viswanadha and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Cellular Physiology and World Journal of Gastroenterology.

In The Last Decade

Chuan‐Chou Tu

17 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan‐Chou Tu Taiwan 12 329 168 161 108 97 17 631
Ser Yue Loo Singapore 11 415 1.3× 117 0.7× 172 1.1× 150 1.4× 87 0.9× 13 736
Hsi‐Hsien Hsu Taiwan 12 309 0.9× 177 1.1× 145 0.9× 46 0.4× 79 0.8× 31 646
Aruljothi Subramaniam United States 7 367 1.1× 205 1.2× 111 0.7× 97 0.9× 87 0.9× 8 653
Tina H. Ong Singapore 9 561 1.7× 249 1.5× 172 1.1× 63 0.6× 98 1.0× 9 886
Julie A. Arlotti United States 15 458 1.4× 89 0.5× 104 0.6× 99 0.9× 63 0.6× 19 775
Trinath P. Das United States 17 447 1.4× 206 1.2× 151 0.9× 147 1.4× 46 0.5× 21 840
Ravindra Kamath India 11 520 1.6× 125 0.7× 114 0.7× 96 0.9× 125 1.3× 11 719
Xuanxuan Dai China 23 683 2.1× 263 1.6× 239 1.5× 42 0.4× 115 1.2× 40 1.2k
Deok‐Beom Jung South Korea 18 534 1.6× 165 1.0× 211 1.3× 37 0.3× 71 0.7× 26 810
Su‐Yu Chien Taiwan 17 341 1.0× 96 0.6× 126 0.8× 81 0.8× 67 0.7× 21 640

Countries citing papers authored by Chuan‐Chou Tu

Since Specialization
Citations

This map shows the geographic impact of Chuan‐Chou Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan‐Chou Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan‐Chou Tu more than expected).

Fields of papers citing papers by Chuan‐Chou Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan‐Chou Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan‐Chou Tu. The network helps show where Chuan‐Chou Tu may publish in the future.

Co-authorship network of co-authors of Chuan‐Chou Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan‐Chou Tu. A scholar is included among the top collaborators of Chuan‐Chou Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan‐Chou Tu. Chuan‐Chou Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hsu, Hsi-Hsien, Wei‐Wen Kuo, Ming-Cheng Chen, et al.. (2019). FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer. Cancers. 11(10). 1576–1576. 72 indexed citations
2.
3.
Jeng, Long‐Bin, Bharath Kumar Velmurugan, Ming‐Cheng Chen, et al.. (2018). Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. Journal of Cellular Physiology. 233(9). 7134–7142. 42 indexed citations
4.
Chen, Ming‐Cheng, Rathinasamy Baskaran, N. Lee, et al.. (2018). CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT‐11‐resistant LoVo colon cancer cells via Gαi‐2 and Gαq/11. Journal of Cellular Physiology. 234(7). 11822–11834. 55 indexed citations
5.
Chen, Ming‐Cheng, Hsi‐Hsien Hsu, Jaw‐Ji Yang, et al.. (2018). Overexpression of ZAKβ in human osteosarcoma cells enhances ZAKα expression, resulting in a synergistic apoptotic effect. Cell Biochemistry and Function. 36(4). 176–182. 1 indexed citations
6.
Hsu, Hsi-Hsien, Ming-Cheng Chen, Cecilia Hsuan Day, et al.. (2017). Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation. World Journal of Gastroenterology. 23(7). 1171–1171. 55 indexed citations
7.
Chen, Ming‐Cheng, Hsi‐Hsien Hsu, Jaw‐Ji Yang, et al.. (2017). Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells. Environmental Toxicology. 33(2). 191–197. 3 indexed citations
8.
Hsu, Hsi‐Hsien, Ming‐Cheng Chen, Rathinasamy Baskaran, et al.. (2017). Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. Journal of Cellular Physiology. 233(7). 5458–5467. 145 indexed citations
9.
Hsu, Hsi-Hsien, Marthandam Asokan Shibu, Tsung‐Jung Ho, et al.. (2016). E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma. Pathology & Oncology Research. 23(3). 477–485. 7 indexed citations
10.
Velmurugan, Bharath Kumar, Chuan‐Chou Tu, Ming‐Cheng Chen, et al.. (2016). Estrogen and ERα enhanced β‐catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK‐3β and β‐TrCP expression. Environmental Toxicology. 32(2). 519–529. 9 indexed citations
11.
Chen, Ming‐Cheng, N. Lee, Hsi‐Hsien Hsu, et al.. (2016). Inhibition of NF‐κB and metastasis in irinotecan (CPT‐11)‐resistant LoVo colon cancer cells by thymoquinone via JNK and p38. Environmental Toxicology. 32(2). 669–678. 47 indexed citations
12.
Chen, Ming-Cheng, N. Lee, Hsi-Hsien Hsu, et al.. (2015). Thymoquinone Induces Caspase-Independent, Autophagic Cell Death in CPT-11-Resistant LoVo Colon Cancer via Mitochondrial Dysfunction and Activation of JNK and p38. Journal of Agricultural and Food Chemistry. 63(5). 1540–1546. 69 indexed citations
13.
Lin, Kuan‐Ho, Marthandam Asokan Shibu, Yueh‐Hsiung Kuo, et al.. (2015). Taiwanin C selectively inhibits arecoline and 4‐NQO‐induced oral cancer cell proliferation via ERK1/2 inactivation. Environmental Toxicology. 32(1). 62–69. 8 indexed citations
14.
Lin, Yueh-Min, Wei‐Wen Kuo, Bharath Kumar Velmurugan, et al.. (2015). Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice. Environmental Toxicology. 31(12). 2045–2056. 12 indexed citations
15.
Tu, Chuan‐Chou, Bharath Kumar Velmurugan, Cecilia Hsuan Day, et al.. (2013). Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins. Journal of Molecular Endocrinology. 51(1). 203–212. 33 indexed citations
16.
Hsu, Hsi-Hsien, Tsung‐Jung Ho, Chuan‐Chou Tu, et al.. (2013). Apicidin-Resistant HA22T Hepatocellular Carcinoma Cells strongly activated the Wnt/β-Catenin Signaling Pathway and MMP-2 Expression via the IGF-IR/PI3K/Akt Signaling Pathway Enhancing Cell Metastatic Effect. Bioscience Biotechnology and Biochemistry. 77(12). 2397–2404. 26 indexed citations
17.
Yang, Jaw‐Ji, et al.. (2010). ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP‐1‐dependent manner. Cancer Science. 101(6). 1374–1381. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ser Yue Loo Breakdown of academic impact, for papers by Hsi‐Hsien Hsu Breakdown of academic impact, for papers by Aruljothi Subramaniam Breakdown of academic impact, for papers by Tina H. Ong Breakdown of academic impact, for papers by Julie A. Arlotti Breakdown of academic impact, for papers by Trinath P. Das Breakdown of academic impact, for papers by Ravindra Kamath Breakdown of academic impact, for papers by Xuanxuan Dai Breakdown of academic impact, for papers by Deok‐Beom Jung Breakdown of academic impact, for papers by Su‐Yu Chien
Rankless by CCL
2026